| Prasugrel (Effient) for acute coronary syndromes in people undergoing percutaneous coronary intervention |
Prasugrel is an alternative to clopidogrel for acute coronary syndrome managed by percutaneous coronary intervention in combination with aspirin. |
| Immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinsons disease |
Information on use of immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinson's disease. |
| Olanzapine long-acting injection (Zyprexa Relprevv) for schizophrenia |
Information about use of olanzapine depot injection (Zyprexa Relprevv) for schizophrenia |
| Brief item: varenicline safety update: serious neuropsychiatric and dermatological adverse events |
Safety update regarding serious neuropsychiatric and dermatological adverse events associated with varenicline (Champix) |
| Brief item: etoricoxib (Arcoxia): be aware of hypertension risk |
Information about hypertension risk associated with use of the COX-2 selective NSAID etoricoxib (Arcoxia) |
| Brief item: new pneumococcal polysaccharide conjugate vaccine (Synflorix) added to the national immunisation schedule |
Information about use of the 10-valent pneumococcal polysaccharide conjugate vaccine, Synflorix, for Streptococcus pneumoniae |
| Brief item: montelukast (Singulair) PBS listed for exercise-induced asthma in children aged 6-14 years |
Information about use of montelukast (Singulair) for exercise-induced asthma in children aged 6–14 years |
| Brief item: Authority listing for ciprofloxacin ear drops extended |
Extension of authority listing for ciprofloxacin ear drops (Ciloxan), 1 November 2009 |
| NPS RADAR December 2009 |
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
